Leminen A - Search Results

1

Prognostic role of CIP2A expression in serous ovarian cancer.

Böckelman C, Lassus H, Hemmes A, Leminen A, Westermarck J, Haglund C, Bützow R, Ristimäki A. Böckelman C, et al. Among authors: leminen a. Br J Cancer. 2011 Sep 27;105(7):989-95. doi: 10.1038/bjc.2011.346. Epub 2011 Sep 6. Br J Cancer. 2011. PMID: 21897396 Free PMC article.

2

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.

Moilanen J, Lassus H, Leminen A, Vaheri A, Bützow R, Carpén O. Moilanen J, et al. Among authors: leminen a. Gynecol Oncol. 2003 Aug;90(2):273-81. doi: 10.1016/s0090-8258(03)00262-2. Gynecol Oncol. 2003. PMID: 12893187

3

Glycodelin in ovarian serous carcinoma: association with differentiation and survival.

Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R. Mandelin E, et al. Among authors: leminen a. Cancer Res. 2003 Oct 1;63(19):6258-64. Cancer Res. 2003. PMID: 14559812

4

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.

Lassus H, Leminen A, Vayrynen A, Cheng G, Gustafsson JA, Isola J, Butzow R. Lassus H, et al. Among authors: leminen a. Gynecol Oncol. 2004 Jan;92(1):31-9. doi: 10.1016/j.ygyno.2003.10.010. Gynecol Oncol. 2004. PMID: 14751135

5

Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma.

Erkinheimo TL, Lassus H, Finne P, van Rees BP, Leminen A, Ylikorkala O, Haglund C, Butzow R, Ristimäki A. Erkinheimo TL, et al. Among authors: leminen a. Clin Cancer Res. 2004 Jan 15;10(2):538-45. doi: 10.1158/1078-0432.ccr-0132-03. Clin Cancer Res. 2004. PMID: 14760075

6

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Joensuu H, Isola J, Nupponen NN, Butzow R. Lassus H, et al. Among authors: leminen a. J Mol Med (Berl). 2006 Aug;84(8):671-81. doi: 10.1007/s00109-006-0054-4. Epub 2006 Apr 11. J Mol Med (Berl). 2006. PMID: 16607561

7

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Nordling S, Joensuu H, Nupponen NN, Butzow R. Lassus H, et al. Among authors: leminen a. Br J Cancer. 2004 Dec 13;91(12):2048-55. doi: 10.1038/sj.bjc.6602252. Br J Cancer. 2004. PMID: 15583695 Free PMC article.

8

Distinct subtypes of serous ovarian carcinoma identified by p53 determination.

Lassus H, Leminen A, Lundin J, Lehtovirta P, Butzow R. Lassus H, et al. Among authors: leminen a. Gynecol Oncol. 2003 Dec;91(3):504-12. doi: 10.1016/j.ygyno.2003.08.034. Gynecol Oncol. 2003. PMID: 14675668

9

Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.

Lassus H, Staff S, Leminen A, Isola J, Butzow R. Lassus H, et al. Among authors: leminen a. Gynecol Oncol. 2011 Jan;120(1):11-7. doi: 10.1016/j.ygyno.2010.09.003. Gynecol Oncol. 2011. PMID: 20937525

10

HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study.

Färkkilä A, Andersson N, Bützow R, Leminen A, Heikinheimo M, Anttonen M, Unkila-Kallio L. Färkkilä A, et al. Among authors: leminen a. Cancer Med. 2014 Jun;3(3):526-36. doi: 10.1002/cam4.230. Epub 2014 Mar 29. Cancer Med. 2014. PMID: 24687970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters